Klinik Araştırma
BibTex RIS Kaynak Göster
Yıl 2023, Cilt: 2 Sayı: 1, 19 - 23, 07.02.2023

Öz

Kaynakça

  • 1. Sundaresan SR, Ashrafi AS. Unusual Mediyastinal Tumors. In: Patterson GA, Cooper JD, Deslauriers J, Lerut AEMR, Rice TW, editors. Pearson’s Thoracic and Esophageal Surgery. 3rd ed. Philadelphia: Churchill Livingstone 2008;1641-52.
  • 2. Etienne-Mastroianni B, Falchero L, Chalabreysse L. Primary sarcomas of thelung. A clinicopathologic study of 12 cases. Lung Cancer 2002;38:283-9.
  • 3. Chhabra A, Soldatos T. Soft-tissuelesions: when can we exclude sarcoma? AJR Am J Roentgenol 2012;199(6):1345-57.
  • 4. Suit HD, Spiro I. Role of radiation in the management of adult patients with sarcoma of soft tissue. Semin Surg Oncol 1994;10(5):347-56.
  • 5. Zahm SH, Fraumeni JF Jr. The epidemiology of soft issue sarcoma. Semin Oncol 1997;24(5):504-14.
  • 6. Benz MR, Czernin J, Allen-Auerbach MS, Tap WD, Dry SM, Elashoff D. FDG-PET/CT imaging predict histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft tissue sarcomas. Clin Cancer Res 2009;15(8):2856-63.
  • 7. Travis WD, Brambilla E, Müler-Hermelink HK, Haris C. Tumors of Pleura World Health Organization Classification of Tumors, Pathology and Genetics Tumours of the Lung, Pleura, Thymusand Heart, Lyon, IARC Pres, 2004;125-44.
  • 8. Athanassiadi K, Kalavrouziotis G, Rondogianni D Loutsidis A, Hatzimichalis A, Bellenis I. Primary chest wall tumors: Early and long-term results of surgical treatment. Eur J Cardiothorac Surg 2001;19:589-93.
  • 9. Wang D, Bosch W, Roberge D, Finkelstein SE, Petersen I, Haddock M. RTOG sarcomaradiati on oncologists reach consensus on gross tumor volume and clinical target volume on computed tomographic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in Radiation Therapy Oncology Group studies. Int J Radiat Oncol Biol Phys 2011;81(4):e525-8.
  • 10. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analyses of 200 cases. Cancer 1978; 41(6):2250-66.
  • 11. Morshuis WJ, Cox AL, Lacquet LK. Primary malignant fibrous histiocytoma of the mediastinum. Thorax 1990; 45(2):154-5.

Primary Lung Malign Mesenchymal Tumors

Yıl 2023, Cilt: 2 Sayı: 1, 19 - 23, 07.02.2023

Öz

Primary mesenchymal tumors are extremely rare tumors of the lung. Mesenchymal tumors constitute about 1% of all cancers and the most common sites are the extremities (59%). Their treatment and prognosis are limited because of their rare occurrence. In this study, three cases of primary lung mesenchymal tumor are presented in the light of the literature.

Kaynakça

  • 1. Sundaresan SR, Ashrafi AS. Unusual Mediyastinal Tumors. In: Patterson GA, Cooper JD, Deslauriers J, Lerut AEMR, Rice TW, editors. Pearson’s Thoracic and Esophageal Surgery. 3rd ed. Philadelphia: Churchill Livingstone 2008;1641-52.
  • 2. Etienne-Mastroianni B, Falchero L, Chalabreysse L. Primary sarcomas of thelung. A clinicopathologic study of 12 cases. Lung Cancer 2002;38:283-9.
  • 3. Chhabra A, Soldatos T. Soft-tissuelesions: when can we exclude sarcoma? AJR Am J Roentgenol 2012;199(6):1345-57.
  • 4. Suit HD, Spiro I. Role of radiation in the management of adult patients with sarcoma of soft tissue. Semin Surg Oncol 1994;10(5):347-56.
  • 5. Zahm SH, Fraumeni JF Jr. The epidemiology of soft issue sarcoma. Semin Oncol 1997;24(5):504-14.
  • 6. Benz MR, Czernin J, Allen-Auerbach MS, Tap WD, Dry SM, Elashoff D. FDG-PET/CT imaging predict histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft tissue sarcomas. Clin Cancer Res 2009;15(8):2856-63.
  • 7. Travis WD, Brambilla E, Müler-Hermelink HK, Haris C. Tumors of Pleura World Health Organization Classification of Tumors, Pathology and Genetics Tumours of the Lung, Pleura, Thymusand Heart, Lyon, IARC Pres, 2004;125-44.
  • 8. Athanassiadi K, Kalavrouziotis G, Rondogianni D Loutsidis A, Hatzimichalis A, Bellenis I. Primary chest wall tumors: Early and long-term results of surgical treatment. Eur J Cardiothorac Surg 2001;19:589-93.
  • 9. Wang D, Bosch W, Roberge D, Finkelstein SE, Petersen I, Haddock M. RTOG sarcomaradiati on oncologists reach consensus on gross tumor volume and clinical target volume on computed tomographic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in Radiation Therapy Oncology Group studies. Int J Radiat Oncol Biol Phys 2011;81(4):e525-8.
  • 10. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analyses of 200 cases. Cancer 1978; 41(6):2250-66.
  • 11. Morshuis WJ, Cox AL, Lacquet LK. Primary malignant fibrous histiocytoma of the mediastinum. Thorax 1990; 45(2):154-5.
Toplam 11 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Araştırma Makaleleri
Yazarlar

Murat Kavas 0000-0001-9025-6605

Cansel Atinkaya Baytemir 0000-0002-8583-3479

Ayşe Ersev 0000-0002-6354-481X

Akın Öztürk 0000-0002-3445-3804

Onur Derdiyok 0000-0001-9994-8501

Selma Aydoğan Eroğlu 0000-0003-4210-6957

Sümeyye Alparslan Bekir 0000-0002-3542-8133

İrfan Yalçınkaya 0000-0002-5860-4080

Yayımlanma Tarihi 7 Şubat 2023
Gönderilme Tarihi 28 Aralık 2022
Yayımlandığı Sayı Yıl 2023 Cilt: 2 Sayı: 1

Kaynak Göster

APA Kavas, M., Atinkaya Baytemir, C., Ersev, A., Öztürk, A., vd. (2023). Primary Lung Malign Mesenchymal Tumors. Istanbul Kent University Journal of Health Sciences, 2(1), 19-23.
AMA Kavas M, Atinkaya Baytemir C, Ersev A, Öztürk A, Derdiyok O, Aydoğan Eroğlu S, Alparslan Bekir S, Yalçınkaya İ. Primary Lung Malign Mesenchymal Tumors. IKUJHS. Şubat 2023;2(1):19-23.
Chicago Kavas, Murat, Cansel Atinkaya Baytemir, Ayşe Ersev, Akın Öztürk, Onur Derdiyok, Selma Aydoğan Eroğlu, Sümeyye Alparslan Bekir, ve İrfan Yalçınkaya. “Primary Lung Malign Mesenchymal Tumors”. Istanbul Kent University Journal of Health Sciences 2, sy. 1 (Şubat 2023): 19-23.
EndNote Kavas M, Atinkaya Baytemir C, Ersev A, Öztürk A, Derdiyok O, Aydoğan Eroğlu S, Alparslan Bekir S, Yalçınkaya İ (01 Şubat 2023) Primary Lung Malign Mesenchymal Tumors. Istanbul Kent University Journal of Health Sciences 2 1 19–23.
IEEE M. Kavas, C. Atinkaya Baytemir, A. Ersev, A. Öztürk, O. Derdiyok, S. Aydoğan Eroğlu, S. Alparslan Bekir, ve İ. Yalçınkaya, “Primary Lung Malign Mesenchymal Tumors”, IKUJHS, c. 2, sy. 1, ss. 19–23, 2023.
ISNAD Kavas, Murat vd. “Primary Lung Malign Mesenchymal Tumors”. Istanbul Kent University Journal of Health Sciences 2/1 (Şubat 2023), 19-23.
JAMA Kavas M, Atinkaya Baytemir C, Ersev A, Öztürk A, Derdiyok O, Aydoğan Eroğlu S, Alparslan Bekir S, Yalçınkaya İ. Primary Lung Malign Mesenchymal Tumors. IKUJHS. 2023;2:19–23.
MLA Kavas, Murat vd. “Primary Lung Malign Mesenchymal Tumors”. Istanbul Kent University Journal of Health Sciences, c. 2, sy. 1, 2023, ss. 19-23.
Vancouver Kavas M, Atinkaya Baytemir C, Ersev A, Öztürk A, Derdiyok O, Aydoğan Eroğlu S, Alparslan Bekir S, Yalçınkaya İ. Primary Lung Malign Mesenchymal Tumors. IKUJHS. 2023;2(1):19-23.